Almodawat Specialized Medical Hospital Company

Almodawat Specialized Medical Hospital Company

TTADAWUL:9594
4.10
SAR
+0.10
(+2.50%)
0.20EPS
19.17P/E
278.59MMarket Cap
Almodawat Specialized Medical Hospital Company
TADAWUL:9594
(Saudi Exchange)

Recent

price

4.10

P/E

ratio

19.17

div

yld

2.42%

ROIC.AI

2022
2023
2024
2025
TTM
SAR
2.47
3.13
3.27
1.71
1.93
Revenue per Share
0.43
0.78
0.26
0.27
0.2
Basic EPS, GAAP
0.21
0.57
-0.38
-0.24
0.03
Free Cash Flow per Basic Share
- -
- -
0.95
0.04
0.1
Dividend per Share
1.3
1.65
1.08
1.24
1.25
Book Value per Share
1.3
1.65
1.08
1.24
1.25
Tangible Book Value per Share
24
24
23
71
72
Basic Weighted Avg Shares
59
74
75
122
139
Sales/Revenue/Turnover
19.54
27.14
10.02
18.09
14.02
Operating Margin (%)
- -
- -
6
8
9
Depreciation Expense
10
19
6
19
15
Net Income, GAAP
3.09
4.39
10.56
6.44
8.92
Effective Tax Rate (%)
17.61
25.02
8.05
15.58
10.56
Profit Margin (%)
2
9
26
29
38
Working Capital
2
2
8
3
23
LT Debt
31
39
77
88
89
Total Equity
- -
52.07
10.67
23.39
15.74
Return on Invested Capital (%)
- -
53.62
11.47
23.92
14.61
Return on Capital (%)
- -
52.94
10.44
22.95
16.64
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
25
29
LT Borrowings
- -
8
21
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
71
71
71
Market Capitalization
337
249
279

Working Capital

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
84
89
104
Cash, Cash Equivalents & STI
12
3
35
Accounts Receivable, Net
- -
74
56
Inventories
- -
7
8
Total Current Liabilities
55
59
67
Payables & Accruals
- -
- -
- -
ST Debt
- -
25
29
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
14.43%
Free Cash Flow
- -
- -
97.4%
Net Income, GAAP
- -
- -
212.44%
Sales/Revenue/Turnover
- -
- -
61.38%
Total Cash Common Dividend
- -
- -
-86.96%

Quarterly Revenue

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19
19
17
22
75
2025
29
27
29
37
122
2026
35
37
- -
- -
- -

Quarterly Earnings Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.03
- -
0.04
0.26
2025
0.23
0.07
0.05
0.07
0.27
2026
0.04
0.04
- -
- -
- -

Quarterly Dividends Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.95
2025
- -
- -
- -
0.03
0.04
2026
0.03
0.04
- -
- -
- -
Business
Al-Modawat Specialized Medical Co. Al-Modawat Specialized Medical Company (9594.SR) operates a general hospital in the southern Aseer region of Saudi Arabia, providing comprehensive healthcare services including cardiology, orthopedics, neurology, obstetrics and gynecology, ophthalmology, dermatology, gastroenterology and endoscopy, internal medicine, pediatrics, psychiatry, general surgery, emergency medicine, otolaryngology, general dentistry, pulmonology, intensive care, urology, laboratory services, and diagnostic radiology; pharmaceutical products; and comprehensive medical check-ups. The company, founded in 2014 and headquartered in Muhayil, Saudi Arabia, at King Abdullah bin Abdulaziz Road, Unit No. 3, primarily serves patients in the Asir region with a focus on high-quality care adhering to international standards through expert Saudi physicians and state-of-the-art facilities. In recent developments, the company is expanding its eastern wing, set for completion in the fourth quarter of 2025, which increases inpatient rooms by 23% and overall capacity by 12% to address rising occupancy; shareholders approved a capital increase and transfer of SAR 2.94 million from the statutory reserve in October 2025; and in July 2025, it appointed a financial adviser for potential transfer to the main market from Nomu-Parallel. Operations remain centered in Saudi Arabia, with revenue derived mainly from medical services (SAR 70.91 million in 2023) and pharmaceutical products (SAR 3.4 million in 2023), supporting its growth in the healthcare facilities sector.